Literature DB >> 25480876

Visceral adiposity and colorectal adenomas: dose-response meta-analysis of observational studies.

N Keum1, D H Lee2, R Kim3, D C Greenwood4, E L Giovannucci5.   

Abstract

BACKGROUND: Obesity-related hormonal and metabolic perturbations implicated in colorectal carcinogenesis are mainly driven by visceral adipose tissue (VAT) rather than subcutaneous adipose tissue (SAT). Yet, most epidemiologic studies have examined the relationship between excess adiposity and colorectal neoplasia using body mass index (BMI) and waist circumference (WC). Due to the inability of BMI and WC to distinguish VAT from SAT, they are likely to have underestimated the true association. PATIENTS AND METHODS: We conducted a dose-response meta-analysis to summarize the relationships between VAT and colorectal adenomas and to examine the value of VAT as an independent risk factor beyond BMI, WC, and SAT. PubMed and Embase were searched through September 2014 to identify relevant observational studies. The summary odds ratio (OR) 95% confidence interval (CI) were estimated using a random-effects model.
RESULTS: In linear dose-response meta-analysis, the summary OR for each 25 cm(2) increase in VAT area was 1.13 (95% CI 1.05-1.21; I(2) = 62%; 6 studies; 2776 cases; range of VAT area = 30-228 cm(2)). The dose-response curve suggested no evidence of nonlinearity (Pnon-linearity = 0.37). In meta-analysis comparing the highest versus lowest category of VAT based on 12 studies, a positive association between VAT and adenomas remained statistically significant even after adjustment for BMI, WC, and SAT. In contrast, adjustment for VAT substantially attenuated associations of BMI, WC, and SAT with adenomas. Across the studies, VAT was more strongly associated with advanced adenomas than nonadvanced adenomas.
CONCLUSIONS: VAT may be the underlying mediator of the observed associations of BMI and WC with adenomas, increasing adenoma risk continuously over a wide range of VAT area. Considering that the joint use of BMI and WC better captures VAT than the use of either one, clinicians are recommended to use both BMI and WC to identify those at high risk for colorectal neoplasia.
© The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  colorectal adenomas; dose–response meta-analysis; observational studies; visceral adipose tissue; visceral adiposity

Mesh:

Year:  2014        PMID: 25480876     DOI: 10.1093/annonc/mdu563

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  21 in total

1.  Circulating Biomarker Score for Visceral Fat and Risks of Incident Colorectal and Postmenopausal Breast Cancer: The Multiethnic Cohort Adiposity Phenotype Study.

Authors:  Loïc Le Marchand; Lynne R Wilkens; Ann M Castelfranco; Kristine R Monroe; Bruce S Kristal; Iona Cheng; Gertraud Maskarinec; Meredith A Hullar; Johanna W Lampe; John A Shepherd; Adrian Franke; Thomas Ernst; Unhee Lim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-03-04       Impact factor: 4.254

2.  Time trends of colorectal cancer incidence and associated lifestyle factors in South Korea.

Authors:  Hayeong Khil; Sung Min Kim; SungEun Hong; Hyeon Min Gil; Eugene Cheon; Dong Hoon Lee; Young Ae Kim; NaNa Keum
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

3.  Impact of Abdominal Adipose Depots and Race on Risk for Colorectal Cancer: A Case-Control Study.

Authors:  Sandra L Gomez-Perez; Vivek Chaudhry; Winnie Mar; Bimal Patel; Giamila Fantuzzi; Sally Freels; Carol A Braunschweig
Journal:  Nutr Cancer       Date:  2017-03-21       Impact factor: 2.900

4.  Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial.

Authors:  Michael N Passarelli; Elizabeth L Barry; Judy R Rees; Leila A Mott; Dennis J Ahnen; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-07       Impact factor: 4.254

5.  Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors.

Authors:  Barbara Altieri; Luigi Barrea; Roberta Modica; Filomena Bottiglieri; Federica de Cicco; Giovanna Muscogiuri; Luisa Circelli; Giovanni Savarese; Carolina Di Somma; Silvia Savastano; Annamaria Colao; Antongiulio Faggiano
Journal:  Endocrine       Date:  2021-09-17       Impact factor: 3.633

6.  Association of Abdominal Visceral Adiposity and Total Fat Mass with Cancer Incidence and Mortality in White and Black Adults.

Authors:  Peter T Katzmarzyk; Justin C Brown; Shengping Yang; Emily F Mire; Xiao-Cheng Wu; Lucio Miele; Augusto C Ochoa; Jovanny Zabaleta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-08-02       Impact factor: 4.090

7.  Assessment of causal effects of visceral adipose tissue on risk of cancers: a Mendelian randomization study.

Authors:  Yao Lu; Haibo Tang; Peiyuan Huang; Jie Wang; Peizhi Deng; Yalan Li; Jie Zheng; Liang Weng
Journal:  Int J Epidemiol       Date:  2022-08-10       Impact factor: 9.685

8.  Quantitative assessment of mesorectal fat: new prognostic biomarker in patients with mid-to-lower rectal cancer.

Authors:  Jiyoung Yoon; Yong Eun Chung; Joon Seok Lim; Myeong-Jin Kim
Journal:  Eur Radiol       Date:  2018-09-18       Impact factor: 5.315

9.  Effects of obesity and weight loss on mitochondrial structure and function and implications for colorectal cancer risk.

Authors:  S P Breininger; F C Malcomson; S Afshar; D M Turnbull; L Greaves; J C Mathers
Journal:  Proc Nutr Soc       Date:  2019-03-22       Impact factor: 6.297

Review 10.  Disparities in Early-Onset Colorectal Cancer.

Authors:  Charles Muller; Ehizokha Ihionkhan; Elena M Stoffel; Sonia S Kupfer
Journal:  Cells       Date:  2021-04-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.